
|Articles|November 6, 2015
Patient Engagement & Rare Diseases Podcast
Author(s)DIA
Advertisement
Durhane Wong-Rieger, President & CEO of the Canadian Organization for Rare Disorders speaks with Global Forum Deputy Editor Alberto Grignolo about patient involvement and engagement, and the future of drug development for rare diseases on DIA’s podcast channel,
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Releases 2025 Financial Report and 2026 Sales and Operations Profit Outlook
2
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
3
Novartis’ Q4 Recap Shows Signs of Looming Patent Cliff
4
FDA Rejects AstraZeneca’s Application for Subcutaneous Indication of Saphnelo
5



